MicroPort® CRM Announces First Implant in Japan of the New Eno™ Pacemaker Family, World's Smallest 1.5T & 3T MRI Conditional Pacemakers*

Clamart, France – September 12, 2019 - MicroPort® CRM, which is a business unit of MicroPort Scientific Corporation, is pleased to announce the first implant of its new Eno™ pacemaker family in Japan.

 

The first Eno™ implant took place at Misato Kenwa Hospital, located in the city Misato. "Eno™ is a great pacemaker for all patients who want a small-sized pacemaker," commented Dr. Makoto Anzai, who performed the implantation. "This tiny pacemaker offers advanced physiologic pacing capabilities and great longevity."

 

Eno™ pacemaker's technology allows patients implanted with compatible leads to undergo MRI (Magnetic Resonance Imaging) scans in either 1.5 Tesla or 3 Tesla machines.

 

The new pacemaker family also features:

 

- AutoMRI™: an automatic mode adaptation upon detection of the MRI field that protects patients who enjoy their optimal pacing settings right up to and right after the scan.

 

- Phi Intelligence™: a permanent adaptive pacing strategy that responds to all levels of patient activity, day and night, evolving and learning with the patient's conditions in order to mimic the natural way the heart works, minimizing artificial intervention.

 

- AF Risk Management™: a unique combination of features that helps physicians to accurately detect Atrial Fibrillation (AF), minimize ventricular pacing and screen for sleep apnea so as to protect patients from developing AF.

 

- Preset Fit™: a set of capabilities including precision programming calibrated through clinical experience and designed to facilitate the implant procedure and device follow up.

 

*Transvenous cardiac pacing systems

 

About MicroPort® CRM

 

Pioneering physiological therapies in cardiac rhythm management. Driven by our expert R&D teams and state-of-the-art manufacturing facilities across the globe, MicroPort® CRM conceives, designs and develops solutions for the management of cardiac rhythm disorders and heart failure. Headquartered in greater Paris, our precise technologies are manufactured in France, Italy, the Dominican Republic; and for the Chinese market, in China. MicroPort® CRM is part of MicroPort® Scientific Corporation.

 

For more information visit www.crm.microport.com